Related references
Note: Only part of the references are listed.The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
Moon Haeng Hur et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
Approaches to quantifying hepatitis B virus covalently closed circular DNA
Henrik Zhang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study
Dong Hyeon Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China
Dao-guang Chen et al.
INFECTIOUS AGENTS AND CANCER (2021)
Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis
Yuan Zhang et al.
BIOENGINEERED (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Interferon Lambda: Toward a Dual Role in Cancer
Ahmed Lasfar et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
KASL clinical practice guidelines for management of chronic hepatitis B
Hyung Joon Yim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Kazumoto Murata et al.
GUT (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B
J. Y. Nam et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Ching-Lung Lai et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases
Sachini U. Siriwardena et al.
CHEMICAL REVIEWS (2016)
Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis
Peter C. Austin
STATISTICS IN MEDICINE (2016)
Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma
Xuan Luo et al.
PLOS ONE (2016)
Investigations of Interferon-Lambda for the Treatment of Cancer
Andrew Stiff et al.
JOURNAL OF INNATE IMMUNITY (2015)
Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin
Lijuan Deng et al.
ONCOTARGET (2015)
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Robert J. Fontana
GASTROENTEROLOGY (2014)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China
Zheng Wei et al.
MEDICAL ONCOLOGY (2014)
The inhibition of hepatitis B virus by APOBEC cytidine deaminases
E. M. Janahi et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Concurrent Infection of Hepatitis B Virus Negatively Affects the Clinical Outcome and Prognosis of Patients with Non-Hodgkin's Lymphoma after Chemotherapy
Jie Chen et al.
PLOS ONE (2013)
A less conservative method to adjust for familywise error rate in neuropsychological research: The Holm's sequential Bonferroni procedure
Katie E. Eichstaedt et al.
NEUROREHABILITATION (2013)
Restoration of TLR3-Activated Myeloid Dendritic Cell Activity Leads to Improved Natural Killer Cell Function in Chronic Hepatitis B Virus Infection
Eric T. T. L. Tjwa et al.
JOURNAL OF VIROLOGY (2012)
Pathogenesis of Non-Hodgkin's Lymphoma
Hendrik Nogai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab
J-P Jais et al.
LEUKEMIA (2008)
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B
RG van der Molen et al.
HEPATOLOGY (2004)
Pathogenesis of hepatitis B virus-related hepatocellular carcinoma:: Old and new paradigms
C Bréchot
GASTROENTEROLOGY (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
GKK Lau et al.
GASTROENTEROLOGY (2003)
Share Paper
